Literature DB >> 23316763

Morbidity and outcome of severe respiratory syncytial virus infection.

Amani A El Kholy1, Nadia A Mostafa, Seham A El-Sherbini, Aliaa A Ali, Reem I Ismail, Rania I Magdy, Mona S Hamdy, May S Soliman.   

Abstract

BACKGROUND: Respiratory syncytial virus (RSV) is the main cause of severe acute respiratory infection (SARI) in infants and young children. This study aimed to identify risk factors for intensive care unit (ICU) admission, prolonged length of stay (PLOS), and mortality in patients hospitalized with SARI caused by RSV.
METHODS: This prospective cohort study included children hospitalized with SARI (according to the World Health Organization definition) and whose laboratory results proved RSV infection during the period from February 2010 to May 2011.
RESULTS: Out of 240 enrolled patients, 24 patients (10%) were admitted to the ICU, 57 patients (24.3%) had a PLOS of >9 days and 12 patients (5%) died. The presence of cyanosis (P = 0.000; OR, 351.7) and lung consolidation (P = 0.006, OR, 9.3) were independent risk factors associated with ICU admission. The need for ICU admission (P = 0.000; OR, 6.1) and lung consolidation (P = 0.008, OR, 2.46) were independent risk factors associated with PLOS. The presence of an underlying congenital heart disease (P = 0.03, OR, 18.3), thrombocytopenia (P = 0.04, OR, 32.86) and mechanical ventilation (P = 0.000; OR, 449.4) were the only independent risk factors associated with mortality in our study.
CONCLUSIONS: Early recognition of risk factors for complicated RSV disease on admission prompts early interventions and early ICU admissions for these children.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Mesh:

Year:  2013        PMID: 23316763     DOI: 10.1111/ped.12051

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  12 in total

Review 1.  Biomarkers of respiratory syncytial virus (RSV) infection: specific neutrophil and cytokine levels provide increased accuracy in predicting disease severity.

Authors:  Paul M Brown; Dana L Schneeberger; Giovanni Piedimonte
Journal:  Paediatr Respir Rev       Date:  2015-05-23       Impact factor: 2.726

2.  Antiviral Activity of TMC353121, a Respiratory Syncytial Virus (RSV) Fusion Inhibitor, in a Non-Human Primate Model.

Authors:  Gabriela Ispas; Anil Koul; Johan Verbeeck; Jennifer Sheehan; Brigitte Sanders-Beer; Dirk Roymans; Koen Andries; Marie-Claude Rouan; Sandra De Jonghe; Jean-François Bonfanti; Marc Vanstockem; Kenneth Simmen; Rene Verloes
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

Review 3.  Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus.

Authors:  Swapnil Subhash Bawage; Pooja Munnilal Tiwari; Shreekumar Pillai; Vida Dennis; Shree Ram Singh
Journal:  Adv Virol       Date:  2013-12-09

4.  Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.

Authors:  K K McLaurin; A M Farr; S W Wade; D R Diakun; D L Stewart
Journal:  J Perinatol       Date:  2016-08-04       Impact factor: 2.521

5.  Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series.

Authors:  Nienke M Scheltema; Angela Gentile; Florencia Lucion; D James Nokes; Patrick K Munywoki; Shabir A Madhi; Michelle J Groome; Cheryl Cohen; Jocelyn Moyes; Kentigern Thorburn; Somsak Thamthitiwat; Hitoshi Oshitani; Socorro P Lupisan; Aubree Gordon; José F Sánchez; Katherine L O'Brien; Bradford D Gessner; Agustinus Sutanto; Asuncion Mejias; Octavio Ramilo; Najwa Khuri-Bulos; Natasha Halasa; Fernanda de-Paris; Márcia Rosane Pires; Michael C Spaeder; Bosco A Paes; Eric A F Simões; Ting F Leung; Maria Tereza da Costa Oliveira; Carla Cecília de Freitas Lázaro Emediato; Quique Bassat; Warwick Butt; Hsin Chi; Uzma Bashir Aamir; Asad Ali; Marilla G Lucero; Rodrigo A Fasce; Olga Lopez; Barbara A Rath; Fernando P Polack; Jesse Papenburg; Srđan Roglić; Hisato Ito; Edward A Goka; Diederick E Grobbee; Harish Nair; Louis J Bont
Journal:  Lancet Glob Health       Date:  2017-10       Impact factor: 26.763

Review 6.  Respiratory syncytial virus hospitalization and mortality: Systematic review and meta-analysis.

Authors:  Renato T Stein; Louis J Bont; Heather Zar; Fernando P Polack; Caroline Park; Ami Claxton; Gerald Borok; Yekaterina Butylkova; Colleen Wegzyn
Journal:  Pediatr Pulmonol       Date:  2016-10-14

7.  Prevalence of respiratory syncytial virus infection among children hospitalized with acute lower respiratory tract infections in Southern India.

Authors:  Sandesh Kini; Bhuvanesh Sukhlal Kalal; Sara Chandy; Ranjani Shamsundar; Anita Shet
Journal:  World J Clin Pediatr       Date:  2019-04-09

8.  Clinical characteristics and outcomes of patients with severe acute respiratory infections (SARI): results from the Egyptian surveillance study 2010-2014.

Authors:  Ashraf Hatem; Sherif Mohamed; Usama E Abu Elhassan; Eman A M Ismael; Magda S Rizk; Amany El-Kholy; Mohamed El-Harras
Journal:  Multidiscip Respir Med       Date:  2019-04-01

9.  Outcomes of patients with Severe Acute Respiratory Infections (SARI) admitted to the intensive care unit: results from the Egyptian Surveillance Study 2010-2014.

Authors:  Usama E Abu Elhassan; Sherif A A Mohamed; Magda S Rizk; Mai Sherif; Mohamed El-Harras
Journal:  Multidiscip Respir Med       Date:  2020-06-09

10.  Mortality in children hospitalised with respiratory syncytial virus infection in Singapore.

Authors:  Ming Wei Lee; Anne En Goh
Journal:  Singapore Med J       Date:  2020-05-27       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.